Lintuzumab and low-dose cytarabine compared to placebo and low-dose cytarabine in patients with untreated acute myeloid leukemia (AML) 60 years and older: Results of a randomized, double-blinded phase 2b study Meeting Abstract
| Authors: | Lancet, J. E.; Sekeres, M. A.; Wood, B. L.; Grove, L. E.; Sandalic, L.; Sievers, E. L.; Jurcic, J. G. |
| Abstract Title: | Lintuzumab and low-dose cytarabine compared to placebo and low-dose cytarabine in patients with untreated acute myeloid leukemia (AML) 60 years and older: Results of a randomized, double-blinded phase 2b study |
| Meeting Title: | 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis |
| Journal Title: | Blood |
| Volume: | 118 |
| Issue: | 21 |
| Meeting Dates: | 2011 Dec 10-13 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2011-11-01 |
| Start Page: | 1543 |
| End Page: | 1544 |
| Language: | English |
| ACCESSION: | WOS:000299597105342 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V118.21.3613.3613 |
| Notes: | --- - Meeting Abstract: 3613 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - DEC 10-13, 2011 - San Diego, CA - "Source: Wos" |
